Jeremy G. Chadwick, Chief Operating Officer at Kymera Therapeutics, Inc. (KYMR), sold 1,383 shares at $30.33 ($42K) on 2025-03-03, disclosed to the SEC on 2025-03-03.
Open-market sale of $42k KYMR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.33 | 1,131 | $34K | 81.5% |
| 2 | $31.00 | 252 | $8K | 18.5% |
| Total | $30.45 avg | 1,383 | $42K | 100% |
| Filing → |
| KYMR | SELL | 2026-04-16 | $590K | — | Filing → |
| KYMR | SELL | 2026-04-01 | $1.9M | — | Filing → |
| KYMR | SELL | 2026-03-25 | $18.0M | — | Filing → |